Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01108081 · ClinicalTrials.gov registry record · Phase 3
Telemedicine Interventions for Obstructive Sleep Apnea (OSA)
A Phase 3 study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- Phase 3
- Development phase
- 169
- Enrollment target
NCT01108081: Completed Phase 3 study, sponsored by VA Office of Research and Development.
NCT01108081 is a Phase 3 study that has completed, run by VA Office of Research and Development. The registered enrollment target is 169 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (78% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01108081, a Phase 3 study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 169 participants
- Enrollment target
Study Summary
This project is investigating whether both moderate-intensity physical activity and dietary weight loss will independently reduce sleep apnea symptoms and improve quality of life.
Primary Outcome
Epworth Sleepiness Scale score, change in score from baseline to 6 months. Total scores range from 0-24, where higher scores indicate more sleepiness.
Interventions
- BEHAVIORAL Diet
- BEHAVIORAL Physical activity
- BEHAVIORAL Health education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 169 participants |
| Start Date | 2010-10 |
| Est. Completion | 2016-01 |
| Phase | Phase 3 |
What the finished NCT01108081 record still lists
NCT01108081 is an interventional study that assigns participants to a tested intervention. The registered 169 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (78% lower).
The record links to 0 conditions, and to 3 interventions - of which Diet is the first listed.
NCT01108081 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01108081 about?
NCT01108081 is a clinical study titled "Telemedicine Interventions for Obstructive Sleep Apnea (OSA)". This project is investigating whether both moderate-intensity physical activity and dietary weight loss will independently reduce sleep apnea symptoms and improve quality of life.
What is the current status of trial NCT01108081?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 169 participants. The study started on 2010-10. Estimated completion is 2016-01.
What interventions are being tested in trial NCT01108081?
The interventions under investigation include: Diet (BEHAVIORAL), Physical activity (BEHAVIORAL), Health education (BEHAVIORAL).
Who is sponsoring clinical trial NCT01108081?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01108081's enrollment target sits among peer trials
169 1459th of 2000 higher than 542 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06191484 · 169 participants · NA
Risk and Resilience to Suicide Following Late-Life Spousal Bereavement
- NCT02016430 · 170 participants · NA
Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)
- NCT02621021 · 170 participants · Phase 2
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
- NCT04094701 · 170 participants · NA
Hip Arthroscopy Postoperative Opioid Demands
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia